LobbyingBiostem Technologies lobbying by quarter
Biostem Technologies BSEM's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $300K. Its first report covers Q3 2024; the issues it reports most are Medicare/Medicaid.
Biostem TechnologiesBSEM
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $300K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2024 | $80K | 1 |
| Q4 2024 | $80K | 1 |
| Q1 2025 | $80K | 1 |
| Q2 2025 | $110K | 1 |
| Q3 2025 | $120K | 1 |
| Q4 2025 | $120K | 1 |
| Q1 2026 | $120K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$770K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)5 reports
- HOUSE OF REPRESENTATIVES2 reports
- White House Office2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ballard Partners | $770K | 8 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Ballard Partners | $60K |
| 04/14for Q1 | Ballard Partners | $120K |
| 01/12for Q4 2025 | Ballard Partners | $120K |
| 25/10/15for Q3 2025 | Ballard Partners | $120K |
| 25/07/14for Q2 2025 | Ballard Partners | $110K |
| 25/04/15for Q1 2025 | Ballard Partners | $80K |
| 25/01/18for Q4 2024 | Ballard Partners | $80K |
| 24/10/17for Q3 2024 | Ballard Partners | $80K |
| 24/09/16for Q3 2024 | Ballard Partners | Under $5,000 |